HR 280 Expressing the sense of the House of Representatives that decades of policies rooted in socialism have stifled United States domestic pharmaceutical drug manufacturing and left the United States exposed to the hostile actions and unfair trade practices of the People's Republic of China

Foreign Trade And International Finance Administrative Law And Regulatory Procedures Asia China Competition And Antitrust Competitiveness, Trade Promotion, Trade Deficits Department Of Health And Human Services Drug Safety, Medical Device, And Laboratory Regulation Food And Drug Administration (fda) Free Trade And Trade Barriers Government Information And Archives Health Technology, Devices, Supplies Manufacturing Prescription Drugs Trade Agreements And Negotiations